Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort …

…, N Suntronwong, H Phowatthanasathian… - Human vaccines & …, 2022 - Taylor & Francis
In light of intermittent supply shortages of individual vaccines and evidence of rare but serious
adverse events after vaccination, heterologous regimens for COVID-19 vaccines have …

Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults

R Yorsaeng, N Suntronwong, H Phowatthanasathian… - Vaccine, 2022 - Elsevier
In June 2021, Thailand was hit by the delta variant of SARS-CoV-2 resulting in the biggest
wave of COVID-19. Due to the widespread delta variant, more than 600 healthcare workers …

Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data

…, N Suntronwong, H Phowatthanasathian… - Vaccine, 2022 - Elsevier
Limited data are available on the responses to heterologous vaccine regimens for SARS-CoV-2,
especially among countries using inactivated and adenoviral-vectored vaccines. A total …

Comparison of the reactogenicity and immunogenicity between two‐dose mRNA COVID‐19 vaccine and inactivated COVID‐19 vaccine followed by an mRNA vaccine …

…, S Kanokudom, H Phowatthanasathian… - Journal of Medical …, 2023 - Wiley Online Library
To compare the reactogenicity and immunogenicity between the two‐dose mRNA COVID‐19
vaccine regimen and one or two doses of inactivated vaccine followed by an mRNA …

[HTML][HTML] Neutralizing antibodies against Omicron BA. 5 among children with infection alone, vaccination alone, and hybrid immunity

…, S Klinfueng, H Phowatthanasathian… - International Journal of …, 2023 - Elsevier
Objectives To assess the binding antibody response and strength of neutralization against
Omicron BA.5 in serum samples from children with different antigen exposures (infection/…

Immunogenicity of heterologous prime/boost inactivated and mRNA COVID-19 vaccine

N Wanlapakorn, R Yorsaeng, H Phowatthanasathian… - medRxiv, 2021 - medrxiv.org
Introduction In August 2021, Thailand imported the BNT162b2 mRNA COVID-19 vaccine.
The prioritised group to receive the BNT162b2 vaccine were health professionals. The …

[HTML][HTML] Immunogenicity of heterologous prime/booster-inactivated and adenoviral-vectored COVID-19 vaccine: real-world data

…, N Suntronwong, H Phowatthanasathian… - 2021 - europepmc.org
Limited data are available on the responses to heterologous vaccine regimens for SARS-CoV-2,
especially among countries using inactivated and adenoviral-vectored vaccines. A total …

Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated followed by an mRNA vaccine in children aged 5 …

N Wanlapakorn, S Kanokudom, H Phowatthanasathian… - medRxiv, 2022 - medrxiv.org
Objective To compare the reactogenicity and immunogenicity between the two-dose mRNA
COVID-19 vaccine regimen and one or two doses of inactivated vaccine followed by an …

[PDF][PDF] IMMUNOGENICITY OF A HETEROLOGOUS INACTIVATED AND mRNA COVID-19 COMBINATION VACCINE REGIMEN

…, N Suntronwong, H Phowatthanasathian… - … Asian Journal of …, 2023 - researchgate.net
Vaccine shortages and side effects have caused many people to have received a mixed anti-corona
virus vaccine regimen using two different types of vaccine (heterologous regimen). …

[PDF][PDF] COVID-19 IN INDIA: STRATEGIES FOR MANAGEMENT

S Yates, H Phowatthanasathian, D Srai, S Bamezai… - imperialbiosciencereview.wordpress …
This paper details four crucial areas of consideration for COVID-19 management in India,
namely, vaccination strategies, resources and supply chain, public structures and social …